Reporting for the PBS NewsHour, Nsikan Akpan highlights a new study co-authored by MIT researchers that examines how many NIH grants lead to new patents and medications. Prof. Pierre Azoulay explains that the study, “provides evidence that the research done in the public sector is useful — it’s relevant for the research done by private-sector firms.”
Newsweek reporter Jessica Wapner writes about a new study by MIT researchers that provides evidence that NIH funding contributes to a large number of patents in the field of biomedicine. The findings indicate that NIH-funded research “is not being done in an ivory tower,” explains Prof. Pierre Azoulay. “Companies use it as input in their own discovery efforts.”
Prof. Krystyn Van Vliet speaks with Samantha Boh of The Straits Times. Van Vliet explains that "My work gives me added motivation because at the end of the day you are not just engineering a new toy or learning something for yourself, but engineering a whole process where the outcome has the potential to restore health."
Nature reporter Elie Dolgin writes about Prof. Pierre Azoulay’s new research that shows NIH funding has a significant impact on innovation in the field of biomedicine. Azoulay explains that from an economic standpoint the U.S. is “under-investing overall” in biomedical research.
Los Angeles Times reporter Melissa Healy writes that a new study by Prof. Pierre Azoulay examining the impact of NIH-funded research shows that NIH funding, “fuels the kinds of innovations that drive the U.S. economy.” Azoulay explains, “NIH public funding expenditures have large effects on the patenting output of the private sector.”
A study by Prof. Pierre Azoulay demonstrates the significant impact of NIH funding on biomedical patents, reports Carolyn Johnson for The Washington Post. Azoulay explains, “if your view was that the research done by academics...[has] no ramifications for the real world and the development of new medicines — well, that view is not correct.”
Graduate student Maimuna Majumder writes for NPR about her research examining what caused an outbreak of the mumps in Arkansas in 2016. Majumder writes that her research shows, “why herd immunity is so important. When we vaccinate, we protect not only ourselves but the most vulnerable members of our communities, too.”
Prof. Canan Dagdeviren and her “Comfortable Decoders” group are developing a new device aimed at deciphering the body’s vital signs and delivering medication, writes Hilary Brueck for Forbes. The device will use “body movement as a powerhouse to monitor and record what's happening inside us,” explains Brueck.
A study by MIT and Harvard researchers provides evidence that a new executive order on immigration could reduce the number of doctors in portions of Appalachia and the Industrial Midwest, reports Sam Petulla for NBC News. "In these places, there are lots of incentives for American-trained doctors and foreign-trained doctors to move and work," explains graduate student Michael Stepner.
Boston Globe reporter Felice Freyer writes that a study by MIT and Harvard researchers examines how an executive order on immigration could impact the number of doctors in Appalachia and the Rust Belt. Doctors from the countries included in the order “handle about 14 million patient visits a year…often settling in areas where American doctors are reluctant to work.”
MIT researchers have developed a drug that could reverse hearing loss by regenerating hair cells in the ear, writes Thomas Tamblyn for The Huffington Post. Hearing loss affects about 45 million Americans and “repairing or regrowing those hair cells would be a major breakthrough,” explains Tamblyn.
By regenerating hair cells in the inner ear that detect and transmit noise to the brain, researchers from MIT and other institutions believe they can help people with hearing loss, writes Jamie Ducharme for Boston Magazine. This method of regenerating cells “holds promise for a vast array of medical issues,” explains Ducharme.
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”
A study by MIT researchers examines how the growth in pet health care spending can provide insights into the increase in human health care costs, writes Austin Frakt for The New York Times. Emotional treatment spending may explain “high and sometimes heroic end-of-life health care spending whether on your dog or on your mother,” explains Prof. Amy Finkelstein.